NASDAQ : TIL

Instil Bio, Inc. — Company profile

Healthcare · Biotechnology · United States

Last price 6.825 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 46.29M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Details

NameInstil Bio, Inc.
SectorHealthcare
IndustryBiotechnology
Employees17
Founded2018
Ipo Date2021-03-19
CeoBronson Crouch
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
Ipo Price20.00
IsinUS45783C2008
Cusip45783C200
Cik1789769
Sic2836
Stock TypeCommon Stock

Key executives

NameTitle
Bronson CrouchChairman and Chief Executive Officer
Dr. Sandeep Laumas M.D.Chief Financial Officer and Chief Business Officer

Contact

Address3963 Maple Avenue, Suite 350, Dallas, Texas 75219, United States
Phone972 499 3350
Websitehttps://instilbio.com